Confetto

Nuclear Medicine Residency Interview Questions and Prep

Practice the residency interview now

Free, no sign-up to start.

Prepare for your nuclear medicine residency interview with questions on theranostics, ABNM training pathways, NRC 10 CFR 35.390 rules, and an example answer.

Practice the residency interview now

Free, no sign-up to start.

A nuclear medicine residency interview focuses on your commitment to molecular imaging and radionuclide therapy, your understanding of radiation safety, and how your prior clinical training fits the pathway you chose. According to the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the American Board of Nuclear Medicine (ABNM), total training after medical school is at least 3 years, starting with 1 preparatory clinical year that includes at least 9 months of direct patient care. This preparatory year is followed by 2 or more years of nuclear medicine residency in ACGME-accredited programs, alongside combined tracks with Diagnostic Radiology or Internal Medicine. Expect questions on why you prefer physiologic and metabolic imaging over purely anatomic modalities, and how you want to practice in a field shaped by new theranostic agents. Sources: SNMMI: Physician Careers in Nuclear Medicine, SNMMI: About SNMMI and Strategic Plans, ABNM: Training Requirements for the Certification Exam. Last checked November 11, 2026.

Know your training pathway before the interview

Interviewers ask early in the conversation why you chose nuclear medicine and why you are applying through your specific training track. Because applicants enter at different stages of graduate medical education, your answer has to match the exact ABNM and ACGME requirements for your background.

Every applicant must complete 1 year of preparatory clinical training before starting nuclear medicine residency, and the ABNM states that at least 9 months of that year must be in a specialty that provides direct patient care. SNMMI notes that a minimum of 18 months of clinical nuclear medicine is required during residency, along with allied health sciences training in medical nuclear physics, radiopharmaceutical chemistry, radiation biology, instrumentation, and computer sciences.

Effective February 2024, the ACGME Board of Directors approved a plan to accredit combined programs, assigning Combined Diagnostic Radiology-Nuclear Medicine to the Radiology Review Committee. Use the table below to keep the official lengths and rules straight when faculty ask about your career plan.

To practice explaining your pathway and clinical background out loud, Confetto runs AI residency mock interviews with follow-up questions. Start your free week to rehearse before your first interview date.

ABNM Nuclear Medicine Training Pathways for US Medical School Graduates
Applicant Background or PathwayRequired Training Length and StructureKey ABNM Notes
Physicians without other specialty training1 preparatory clinical year (at least 9 months direct patient care) + 36 months of training at an institution with an ACGME-accredited Nuclear Medicine programSNMMI states total training after medical school graduation is at least 3 years (1 or more preparatory years and 2 or more residency years).
Combined Nuclear Medicine and Diagnostic Radiology (separately accredited programs)5 years total across separately ACGME-accredited NM and DR programs, including 16 to 24 months of Nuclear Medicine trainingPhysicians may be designated as a Nuclear Medicine resident or a Diagnostic Radiology resident during training.
Nuclear Medicine or Nuclear Radiology during Diagnostic Radiology residency16 months (64 weeks, where 1 month is one 4-week rotation) of NM training during 4 years of DR residencyCompleted at an institution with an ACGME-accredited Nuclear Medicine or Nuclear Radiology program.
Nuclear Medicine before or after Diagnostic Radiology residency, or Nuclear Radiology fellowshipNuclear Medicine training during an ACGME-accredited DR program + additional training in an ACGME-accredited NM program or Nuclear Radiology fellowshipTotals 16 months of nuclear medicine training across residency and fellowship.
Combined Internal Medicine and Nuclear Medicine4 years (48 months) of combined training in accredited IM and NM programsRequires ABIM and ABNM approval before starting and leads to admissibility to certification in both specialties.
Physicians certified or eligible by another ABMS member boardUp to 1 year of credit for prior training + 2 years of Nuclear Medicine training in an ACGME-accredited NM programApplies to specialty training other than Diagnostic Radiology.

How to talk about molecular imaging and theranostics

When an interviewer asks "Why nuclear medicine?", they are testing whether you understand what separates the specialty from diagnostic radiology or medical oncology. SNMMI defines scintigraphy as the use of radionuclides to produce images of the body's organs, noting that it differs from x-ray radiography because it studies the physiologic and metabolic processes of the body rather than anatomy alone.

Be ready to explain the mechanism in plain words. In isotopic imaging, a small amount of radioactive material is combined with a targeting compound to form a radiopharmaceutical that is injected, inhaled, or ingested. As the isotope decays, it emits gamma rays detected by a gamma camera or a positron emission tomography (PET) scanner, producing scintillations that computer systems turn into images, including tomographic imaging with single photon emission computed tomography (SPECT) or PET.

Faculty also want to hear what excites you about where the field is going. SNMMI describes nuclear medicine as undergoing a renaissance driven by the steady introduction and approval of new radiopharmaceuticals, theranostics, and instrumentation. Be comfortable discussing the clinical impact of the areas SNMMI highlights:

  • Theranostics and prostate cancer: FDA approval of new PSMA-targeted prostate imaging and therapy agents that pair diagnostic target localization with radionuclide treatment.
  • Emerging PET tracers: Breakthrough research in FAPI (fibroblast activation protein inhibitor) PET/CT.
  • SPECT and AI: The introduction of new generic SPECT agents and advances in artificial intelligence for image reconstruction and interpretation.
  • Established unsealed source therapies: Using radioisotopes to treat hyperthyroidism, thyroid cancer, blood dyscrasias, solid tumors, and painful bone metastases.
  • In-vitro testing: Competitive binding and radioimmunoassay techniques used to measure peptide hormones, drugs, and other biological substances.

Discussing radiation safety and NRC 10 CFR 35.390 rules

To sit for the ABNM certification exam and practice independently with therapeutic radiopharmaceuticals, you must meet U.S. Nuclear Regulatory Commission (NRC) training and experience requirements to become an Authorized User (AU) under 10 CFR 35.390 for the medical use of unsealed byproduct material requiring a written directive.

Bringing up Authorized User training during your interview shows program directors that you understand daily resident responsibilities. Under 10 CFR 35.390, you must complete a minimum of 700 hours of training and experience. At least 200 of those hours must be classroom and laboratory training in 5 areas: radiation physics and instrumentation, radiation protection, mathematics pertaining to the use and measurement of radioactivity, chemistry of byproduct material for medical use, and radiation biology. Reviewing case histories or interpreting scans cannot be counted toward those 200 classroom and laboratory hours.

By our calculation from the ABNM Training Requirements, the 200-hour minimum of classroom and laboratory instruction accounts for at least 28.6% of the 700 total hours required by the NRC, leaving up to 500 hours for supervised work experience under an Authorized User. That supervised work experience under 10 CFR 35.390 and 10 CFR 35.290 (imaging and localization studies) covers hands-on tasks that interviewers sometimes turn into safety scenarios:

  • Ordering, receiving, and unpacking radioactive materials safely and performing the required radiation surveys.
  • Eluting generator systems to prepare radioactive drugs for imaging and localization studies, measuring and testing the eluate for radionuclidic purity, and processing the eluate with reagent kits (supervised by an Authorized User or an authorized Nuclear Pharmacist).
  • Performing quality control procedures on dose calibrators and checking survey meters for proper operation.
  • Calculating, measuring, and safely preparing patient or human research subject dosages, and using administrative controls to prevent medical events.
  • Containing spilled byproduct material safely and carrying out proper decontamination procedures.
  • Administering dosages requiring a written directive under an Authorized User across oral sodium iodide I-131 and parenteral therapeutic radioactive drugs.

Nuclear medicine residency interview questions to practice

Our team wrote the practice prompts below based on the clinical, regulatory, and pathway requirements that the ABNM, ACGME, and SNMMI set for trainees. Practice answering each in 90 seconds to 2 minutes.

When faculty ask clinical scenario questions on on-call triage, urgent scans in pregnancy, or protocol modifications, use a 4-step framework: state the immediate clinical priority, verify patient history and contraindications, apply the ALARA (as low as reasonably achievable) principle or protocol modification, and communicate your plan clearly to the referring team and technologist.

  • Motivation and specialty fit: Why did you choose nuclear medicine over a standalone diagnostic radiology or medical oncology residency, and how does studying physiologic and metabolic processes fit your clinical strengths?
  • Pathway clarity: Walk me through your prior clinical training. How has your preparatory clinical year (or prior residency) prepared you to serve as a nuclear medicine consultant?
  • Theranostics: SNMMI describes a renaissance in nuclear medicine with FDA-approved PSMA-targeted imaging and therapy agents. How do you see the nuclear medicine physician's role on the multidisciplinary oncology team evolving over the next 5 years?
  • Patient communication on radiation: A patient scheduled for a diagnostic scan is worried about radiation exposure. Knowing that SNMMI notes the radiation received is very small and often less than a comparable x-ray procedure, how do you counsel them?
  • Urgent scan in pregnancy (ALARA scenario): A pregnant patient is referred for an urgent V/Q scan for suspected life-threatening pulmonary embolism. How do you weigh maternal stabilization, counsel the patient on fetal radiation risk, and modify the protocol using the ALARA principle (such as starting with a reduced-dose perfusion-only phase)?
  • On-call triage scenario: You are on call and receive simultaneous urgent requests for a V/Q scan to rule out acute pulmonary embolism and a hepatobiliary (HIDA) scan for suspected acute cholecystitis. Walk through how you assess hemodynamic stability, check radiopharmaceutical preparation times, and prioritize the studies.
  • Protocol modification and contraindications: A patient referred for captopril renal scintigraphy to evaluate renovascular hypertension has a documented ACE inhibitor allergy. How do you verify the reaction, adjust the imaging protocol or pharmacologic intervention with the referring physician, and ensure patient safety?
  • Thyroid therapy scenario: Walk me through the differences in your priorities and radiation safety counseling when preparing an oral NaI-131 administration for benign hyperthyroidism versus a higher-dose administration for malignant thyroid disease.
  • Radiation spill and safety: You are working in the hot lab and a technologist drops a vial of unsealed byproduct material. What are your immediate priorities for containment, decontamination, and survey meter checks?
  • Preventing medical events: The NRC requires administrative controls to prevent medical events when administering unsealed byproduct material requiring a written directive. Tell me about a time in your clinical training when a verification step caught an error before it reached a patient.
  • Cardiac stress testing: ACGME and ABNM rules require residents to actively supervise cardiovascular stress tests, not just interpret the cardiac images. Tell me about your experience managing acute patient issues or working with stress lab staff.
  • Scholarly activity and quality control: Have you participated in a quality assurance/quality control (QA/QC) project, journal club, or research presentation, and what would you like to investigate during residency?
  • Combined pathway fit (for DR/NM or IM/NM applicants): Why are you pursuing dual certification or the 16-month nuclear medicine pathway instead of waiting to do a fellowship after residency?

Questions to ask faculty about ACGME case logs and training

At the end of every faculty interview, ask how residents meet specific ACGME and ABNM case log minimums, and how the department structures hybrid imaging, cross-sectional CT training, radiopharmacy operations, and therapy clinics.

Per the ABNM's summary of ACGME Nuclear Medicine Program Requirements, every trainee must log specific clinical numbers and maintain Basic and Advanced Cardiac Life Support (BLS and ACLS) certification. By our calculation from the ABNM case minimums, the 10 required oral NaI-131 cases and 10 required parenteral written-directive cases make up at least 20 of your 35 required therapeutic administrations (about 57%), leaving 15 cases that can come from either category or additional non-Y-90 therapies.

  • Therapeutic volume: "To meet the ABNM minimum of 35 therapeutic administrations excluding Y-90 microspheres, including at least 10 oral NaI-131 cases and 10 parenteral cases across at least 2 FDA-approved radiopharmaceuticals, which parenteral agents do residents administer most frequently here?"
  • Stress test supervision: "Since required cardiovascular stress tests must include active supervision of exercise or pharmacologic stress rather than image interpretation alone, how is resident coverage scheduled in the cardiac stress lab?"
  • Cross-sectional diagnostic CT training: "How does the curriculum structure dedicated diagnostic CT training so residents build confidence interpreting the concurrent contrast-enhanced CTs on hybrid PET/CT and SPECT/CT studies?"
  • Radiopharmacy and cyclotron infrastructure: "Does the department operate an on-site cyclotron and radiopharmacy for emerging tracers like PSMA and FAPI, and how do residents complete their 10 CFR 35.290 generator elution and kit preparation experience?"
  • Hybrid imaging and tumor boards: "How much hands-on time do residents get on both PET/CT and SPECT/CT, and do residents present nuclear medicine and molecular imaging data directly at multidisciplinary tumor boards?"
  • Board exam and longitudinal prep: "How does the didactic curriculum integrate the 200 hours of NRC classroom and laboratory training with preparation for the online ABNM In-Training Exam and CertLink In-Training assessments?"
ABNM and ACGME Minimum Clinical Case Requirements to Discuss on Interview Day
Clinical CategoryMinimum Required CasesSpecific ABNM and NRC Rules
Cardiovascular stress testsSupervised studies requiredMust include supervision of exercise or pharmacologic stress tests, not just review and interpretation of nuclear cardiac images.
Pediatric nuclear medicineRequired clinical rotation experienceRequired across all ACGME-equivalent nuclear medicine training tracks.
Total therapeutic administrations35 cases minimumExcludes Y-90 microspheres. Must include the oral and parenteral minimums below.
Oral NaI-131 administrations10 cases minimumIncludes cases for both malignant disease and benign disease across low and high dosage categories.
Parenteral therapeutic administrations10 cases minimumFor uses requiring a written directive. Must include at least 2 different US FDA-approved radiopharmaceuticals.

2-week preparation checklist for your interview

Use this 2-week plan written by our team to organize your preparation before interview day.

  • Days 1 to 3 (Pathway and credentials audit): Map your training timeline against the ABNM requirements. If you completed any clinical, diagnostic radiology, or nuclear medicine training outside the US or Canada, review the ABNM credit rules so you can explain cleanly how many years of US training you need.
  • Days 4 to 6 (Clinical, triage, and safety review): Review how gamma cameras, SPECT/CT, and PET/CT work, the difference between physiologic imaging and radiography, on-call triage and ALARA pregnancy protocols, and the 10 CFR 35.390 and 35.290 supervised work tasks (generator elution, radionuclidic purity testing, dose calibrator QC, and written directives).
  • Days 10 to 12 (Program-specific dossier): For each program on your schedule, look up its hybrid scanners (PET/CT, SPECT/CT), diagnostic CT cross-training rotations, radiopharmacy or cyclotron facilities, theranostics volume, and faculty interests in areas like PSMA, FAPI PET/CT, or AI.
  • Days 13 to 14 (Timed mock interviews): Run full spoken practice sessions answering each question in under 2 minutes. Start your free week on Confetto to practice your answers out loud and get rubric-based feedback before your interview.

IMG rules, alternate pathways, and ABNM board eligibility

Show details

If you trained outside the United States and Canada, program directors will ask during your interview how your prior graduate medical education applies toward ABNM board eligibility and NRC Authorized User training. Be ready to explain that a US Nuclear Medicine program director can ask the ABNM to accept your foreign preparatory clinical year as equivalent (or designate you as an "exceptionally qualified applicant" with the selection and GME committees), and can submit a formal request to the ABNM for up to 1 year of credit for prior international Diagnostic Radiology training (requiring at least 2 years of US Nuclear Medicine training) or up to 2 years of credit for prior international Nuclear Medicine training (requiring at least 1 year of US Nuclear Medicine training). If you are already certified in Nuclear Medicine or Radiology outside the US and Canada, you can also discuss the ABR Alternate Pathway (which requires at least 16 months of US Nuclear Medicine training) or the ABNM Alternate Pathway (which requires 3 years of full-time experience as a resident, fellow, visiting scholar, or faculty member in an ACGME-accredited Nuclear Medicine department, alongside all 700 hours of NRC 10 CFR 35.390 training and clinical case requirements).

Practice question

Why are you choosing to train in Nuclear Medicine now, and what part of the clinical work appeals to you most?

See an example answer

Example answer written by our team. The applicant is invented. "During my internal medicine preliminary year, I cared for several patients with metastatic castration-resistant prostate cancer who were referred for PSMA PET/CT and subsequent radioligand therapy. Watching how a single molecular target could guide staging and then deliver targeted radiation therapy changed how I thought about imaging. What draws me to nuclear medicine over purely anatomic imaging is that scintigraphy and PET let us measure physiologic and metabolic processes in real time. I also enjoy the direct patient care side of the specialty. In residency, I am excited that we do not only sit in a reading room. We supervise cardiac stress tests, counsel patients on radiation safety before oral I-131 treatments for benign hyperthyroidism or thyroid cancer, and manage parenteral therapies in the clinic. Having 9 months of inpatient and clinic responsibility this year taught me how much referring oncologists and cardiologists rely on clear consultations. I want to train in a program where I can build strong diagnostic PET/CT and SPECT/CT skills while completing my NRC Authorized User training in a busy theranostics clinic."

It names a concrete clinical experience from the required preparatory year, explains the difference between physiologic molecular imaging and anatomic imaging, and references real residency duties from the ABNM and ACGME requirements (PSMA theranostics, cardiac stress test supervision, oral I-131 counseling, and NRC Authorized User training) without sounding recited.

Frequently asked questions

How long is a nuclear medicine residency and what are the prerequisites?

According to SNMMI and the ABNM, total training after medical school graduation is at least 3 years. Before starting nuclear medicine training, you must complete 1 preparatory clinical year that includes at least 9 months in a specialty providing direct patient care, followed by 2 or more years of nuclear medicine residency in an ACGME-accredited program.

How do combined Diagnostic Radiology and Nuclear Medicine pathways work?

The ABNM outlines several routes for Diagnostic Radiology trainees: a 5-year combined residency in separately accredited programs with 16 to 24 months of nuclear medicine, 16 months (64 weeks) of nuclear medicine integrated within a 4-year Diagnostic Radiology residency, or nuclear medicine training during radiology residency followed by a nuclear medicine residency or nuclear radiology fellowship.

What are the NRC 10 CFR 35.390 Authorized User requirements in residency?

Under 10 CFR 35.390, residents must complete at least 700 hours of training and experience applicable to unsealed byproduct material requiring a written directive. This includes a minimum of 200 hours of classroom and laboratory training (covering radiation physics, protection, math, chemistry, and biology) plus supervised work experience in generator elution, survey meter and instrument quality control, spill containment, and administering written-directive dosages.

What are the ACGME minimum case log numbers for nuclear medicine residents?

Residents must log supervised cardiovascular stress tests (supervising the exercise or pharmacologic test, not only reading the images), pediatric nuclear medicine studies, and at least 35 therapeutic administrations excluding Y-90 microspheres. Those 35 therapies must include at least 10 oral NaI-131 cases (covering both malignant and benign disease) and at least 10 parenteral administrations across at least 2 FDA-approved radiopharmaceuticals.

What recent advances in molecular imaging and theranostics should I know for my interview?

SNMMI highlights a renaissance in the specialty led by the FDA approval of PSMA-targeted prostate cancer imaging and therapy agents, breakthrough research in FAPI PET/CT, new generic SPECT agents, and advances in artificial intelligence. Being ready to discuss how these tools combine physiological diagnosis with targeted radionuclide therapy will help you answer questions about the future of the field.

Sources